chartexchange

MLYS
Mineralys Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:57 PM EST
13.78USD-4.800%(-0.70)1,392,766
After-hoursNov 18, 2026 4:34:30 PM EST
13.65USD-0.979%(-0.13)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Radnor, PA, USA
Previous Close
$14.48
Beta
1.61
52-Week High
$45.00 2025-11-20
52-Week Low
$13.72 2026-11-18
SMA 50
$21.72
SMA 200
$25.90
Avg. Vol 10D
1.82M
Avg. Vol 30D
1.82M
Avg. Vol 90D
1.30M
Relative Vol
0.76
60.94M
0.4100%
3,300,000
1,330
MLYS Profile

at mineralys therapeutics we aim to redefine hypertension diagnosis, management and treatment. we are driven to break the "trial and failure" approach to hypertension management and bring a personalized approach to the management of hypertension.

MLYS Performance
PeriodPriceDateChangeBeta
1W15.502026-11-12-11.03%1.115
1M20.922026-10-19-34.08%2.749
3M26.952026-08-19-48.83%2.405
6M26.032026-05-19-47.02%1.688
1Y42.122025-11-19-67.26%1.612
2Y12.862024-11-19+7.23%—
5Y18.442023-02-10-25.22%1.036
MLYS Stock Summary

Mineralys Therapeutics, Inc. Common Stock (NASDAQ:MLYS) stock price today is $13.79, and today's volume is 1,392,766. MLYS is down 4.765% today. The 30 day average volume is 1.82M. MLYS market cap is $1.22B with 88.56M shares outstanding.